{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:26:20Z","timestamp":1773275180000,"version":"3.50.1"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Spanish Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["BIO2010-20696"],"award-info":[{"award-number":["BIO2010-20696"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["BIO2013-47228-R"],"award-info":[{"award-number":["BIO2013-47228-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"crossref","award":["SAF2014-52400-R"],"award-info":[{"award-number":["SAF2014-52400-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Comunidad Autonoma de Madrid","award":["S2013\/ABI-2906"],"award-info":[{"award-number":["S2013\/ABI-2906"]}]},{"name":"Biotherapix, S.L.U.","award":["-"],"award-info":[{"award-number":["-"]}]},{"name":"FEDER Funds","award":["-"],"award-info":[{"award-number":["-"]}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["RyC2010-06516"],"award-info":[{"award-number":["RyC2010-06516"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Spanish Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["AGL2015-64290-R"],"award-info":[{"award-number":["AGL2015-64290-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["Miguel Servet - CP14\/00121"],"award-info":[{"award-number":["Miguel Servet - CP14\/00121"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0166902","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T18:37:11Z","timestamp":1481654231000},"page":"e0166902","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies"],"prefix":"10.1371","volume":"11","author":[{"given":"Ver\u00f3nica","family":"Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Fern\u00e1ndez-Algar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena G.","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Pernas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Parro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Garc\u00eda-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Alcam\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Tor\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Abia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2213-8353","authenticated-orcid":true,"given":"Carlos","family":"Briones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,12,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"13910","DOI":"10.1073\/pnas.96.24.13910","article-title":"Mutation rates among RNA viruses","volume":"96","author":"JW Drake","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2217\/fvl.14.41","article-title":"Variability in the mutation rates of RNA viruses","volume":"9","author":"M Combe","year":"2014","journal-title":"Future Virol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/MMBR.05023-11","article-title":"Viral quasispecies evolution","volume":"76","author":"E Domingo","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0966-842X(96)20011-3","article-title":"On the nature of virus quasispecies","volume":"4","author":"M Eigen","year":"1996","journal-title":"Trends Microbiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tim.2012.08.010","article-title":"The impact of quasispecies dynamics on the use of therapeutics","volume":"20","author":"C Perales","year":"2012","journal-title":"Trends Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11633630-000000000-00000","article-title":"HIV-1 Antiretroviral resistance: Scientific principles and clinical applications","volume":"72","author":"MW Tang","year":"2012","journal-title":"Drugs"},{"key":"ref7","first-page":"132","article-title":"2015 Update of the drug resistance mutations in HIV-1","volume":"23","author":"AM Wensing","year":"2015","journal-title":"Top Antivir Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e1001005","DOI":"10.1371\/journal.ppat.1001005","article-title":"Quasispecies theory and the behavior of RNA viruses","volume":"6","author":"AS Lauring","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.virusres.2011.09.018","article-title":"Quasispecies as a matter of fact: Viruses and beyond","volume":"162","author":"S Ojosnegros","year":"2011","journal-title":"Virus Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1128\/JVI.74.8.3543-3547.2000","article-title":"Memory in viral quasispecies","volume":"74","author":"CM Ruiz-Jarabo","year":"2000","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/jmbi.2001.5232","article-title":"Duration and fitness dependence of quasispecies memory","volume":"315","author":"CM Ruiz-Jarabo","year":"2002","journal-title":"J Mol Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0022-2836(03)00661-2","article-title":"Memory in retroviral quasispecies: Experimental evidence and theoretical model for human immunodeficiency virus","volume":"331","author":"C Briones","year":"2003","journal-title":"J Mol Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gene.2006.07.037","article-title":"Minority memory genomes can influence the evolution of HIV-1 quasispecies <italic>in vivo<\/italic>","volume":"384","author":"C Briones","year":"2006","journal-title":"Gene"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/517433","article-title":"Human immunodeficiency virus proviral DNA from peripheral blood and lymph nodes demonstrates concordant resistance mutations to zidovudine (codon 215) and didanosine (codon 74)","volume":"177","author":"D Mayers","year":"1998","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1086\/606117","article-title":"Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants","volume":"200","author":"Y Quan","year":"2009","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1742-4690-4-78","article-title":"HIV-1 drug-resistance and drug-dependence","volume":"4","author":"C Baldwin","year":"2007","journal-title":"Retrovirology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAD.0b013e3283427dcb","article-title":"Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy","volume":"25","author":"DD Goodman","year":"2011","journal-title":"AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy","volume":"5","author":"JA Johnson","year":"2008","journal-title":"PLoS Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":"Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure. A systematic review and pooled analysis","volume":"305","author":"JZ Li","year":"2011","journal-title":"J Am Med Assoc"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/595703","article-title":"Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients","volume":"48","author":"KJ Metzner","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref21","first-page":"662","article-title":"Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure","volume":"201","author":"R Paredes","year":"2010","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/596736","article-title":"Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes","volume":"199","author":"BB Simen","year":"2009","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.3390\/v6093428","article-title":"Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naive subjects.","volume":"6","author":"S Gupta","year":"2014","journal-title":"Viruses"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e0135941","DOI":"10.1371\/journal.pone.0135941","article-title":"Longitudinal detection and persistence of minority drug-resistant populations and their effect on salvage therapy","volume":"10","author":"M Nishizawa","year":"2015","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/jac\/dku470","article-title":"Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon","volume":"70","author":"A Zoufaly","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2010.10.001","article-title":"Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naive patients","volume":"50","author":"KJ Metzner","year":"2011","journal-title":"J Clin Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/QAD.0b013e3283034953","article-title":"Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy","volume":"22","author":"O Peuchant","year":"2008","journal-title":"AIDS"},{"key":"ref28","first-page":"93","article-title":"Minority report: Hidden memory genomes in HIV-1 quasispecies and possible clinical implications","volume":"10","author":"C Briones","year":"2008","journal-title":"AIDS Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/infdis\/jis925","article-title":"Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure","volume":"207","author":"JZ Li","year":"2013","journal-title":"J Infect Dis"},{"key":"ref30","first-page":"672","article-title":"Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment-experienced patients","volume":"201","author":"EK Halvas","year":"2010","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/QAD.0000000000000267","article-title":"Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure","volume":"28","author":"S Mohamed","year":"2014","journal-title":"AIDS"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fmicb.2012.00329","article-title":"Challenges and opportunities in estimating viral genetic diversity from next-generation sequencing data","volume":"3","author":"N Beerenwinkel","year":"2012","journal-title":"Front Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e6079","DOI":"10.1371\/journal.pone.0006079","article-title":"Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use","volume":"4","author":"T Le","year":"2009","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e86771","DOI":"10.1371\/journal.pone.0086771","article-title":"Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure","volume":"9","author":"MA Vandenhende","year":"2014","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11908-014-0401-5","article-title":"Next-generation sequencing to help monitor patients infected with HIV: Ready for clinical use?","volume":"16","author":"RM Gibson","year":"2014","journal-title":"Curr Infect Dis Rep"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1742-4690-10-18","article-title":"Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of low-frequency drug resistance mutations in HIV-1 DNA","volume":"10","author":"W Shao","year":"2013","journal-title":"Retrovirology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1093\/nar\/gkq655","article-title":"Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies","volume":"38","author":"O Zagordi","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1469-0691.12056","article-title":"Next-generation sequencing technology in clinical virology","volume":"19","author":"MR Capobianchi","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/cid\/cit125","article-title":"Clinical implications of HIV-1 minority variants","volume":"56","author":"JZ Li","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/fvl.10.77","article-title":"New technology to detect low-level drug-resistant HIV variants","volume":"6","author":"A Gega","year":"2011","journal-title":"Future Virol"},{"key":"ref41","first-page":"3666","article-title":"Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay","volume":"51","author":"GQ Zhang","year":"2013","journal-title":"J Microbiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1128\/JCM.37.8.2533-2537.1999","article-title":"Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms","volume":"37","author":"M Vahey","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nm0796-753","article-title":"Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays","volume":"2","author":"MJ Kozal","year":"1996","journal-title":"Nat Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1128\/JCM.38.8.3022-3028.2000","article-title":"Comparative evaluation of three human immunodeficiency virus genotyping systems: the HIV-GenotypR method, the HIV PRT GeneChip assay, and the HIV-1 RT line probe assay","volume":"38","author":"JW Wilson","year":"2000","journal-title":"J Clin Microbiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00216-007-1775-0","article-title":"Genotypic resistance testing in HIV by arrayed primer extension","volume":"391","author":"M Schanne","year":"2008","journal-title":"Anal Bioanal Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/tmi.12289","article-title":"Development of a simple microarray for genotyping HIV-1 drug resistance mutations in the reverse transcriptase gene in rural Tanzania","volume":"19","author":"P Masimba","year":"2014","journal-title":"Trop Med Int Health"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-1702(99)00120-3","article-title":"Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy","volume":"66","author":"C Briones","year":"2000","journal-title":"Virus Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1093\/emboj\/19.21.5752","article-title":"Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance","volume":"19","author":"A Mas","year":"2000","journal-title":"EMBO J"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jmb.2006.09.073","article-title":"Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine","volume":"365","author":"CE Cases-Gonzalez","year":"2007","journal-title":"J Mol Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jmb.2007.11.021","article-title":"Mechanistic insights into the role of Val75 of HIV-1 reverse transcriptase in misinsertion and mispair extension fidelity of DNA synthesis","volume":"375","author":"T Matamoros","year":"2008","journal-title":"J Mol Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2164-7-117","article-title":"Microarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment","volume":"7","author":"V Martin","year":"2006","journal-title":"BMC Genomics"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.virol.2010.10.013","article-title":"Structural analysis provides insights into the modular organization of picornavirus IRES","volume":"409","author":"N Fernandez","year":"2011","journal-title":"Virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/nar\/gkt841","article-title":"End-to-end crosstalk within the hepatitis C virus genome mediates the conformational switch of the 3&apos;X-tail region","volume":"42","author":"C Romero-Lopez","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias","volume":"19","author":"BM Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"ref55","first-page":"768","article-title":"Cluster analysis of multivariate data\u2014Efficiency vs interpretability of classifications","volume":"21","author":"EW Forgy","year":"1965","journal-title":"Biometrics"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1109\/TPAMI.2002.1017616","article-title":"An efficient k-means clustering algorithm: Analysis and implementation","volume":"24","author":"T Kanungo","year":"2002","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"ref57","first-page":"284","article-title":"Information theory, inference and learning algorithms","author":"D MacKay","year":"2003"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1214\/aoms\/1177729885","article-title":"Sample criteria for testing outlying observations","volume":"21","author":"FE Grubbs","year":"1950","journal-title":"Ann Math Stat"},{"key":"ref59","author":"V Barnett","year":"1994"},{"key":"ref60","author":"B Iglewicz","year":"1993"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1093\/nar\/gnh088","article-title":"Structural analysis of hepatitis C RNA genome using DNA microarrays","volume":"32","author":"M Martell","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1093\/nar\/gkr560","article-title":"Structural basis for the biological relevance of the invariant apical stem in IRES-mediated translation","volume":"39","author":"N Fernandez","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.1093\/nar\/gks927","article-title":"The folding of the hepatitis C virus internal ribosome entry site depends on the 3&apos; end of the viral genome","volume":"40","author":"C Romero-Lopez","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/JCM.41.4.1586-1593.2003","article-title":"Accuracy of the TRUGENE HIV-1 genotyping kit","volume":"41","author":"RM Grant","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JCM.43.2.813-817.2005","article-title":"Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer","volume":"43","author":"SH Eshleman","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1080\/09540121.2015.1114992","article-title":"Factors associated with antiretroviral treatment uptake and adherence: a review. Perspectives from Australia, Canada, and the United Kingdom","volume":"27","author":"K Bolsewicz","year":"2015","journal-title":"AIDS Care"},{"key":"ref67","first-page":"77","article-title":"European recommendations for the clinical use of HIV drug resistance testing: 2011 update","volume":"13","author":"AM Vandamme","year":"2011","journal-title":"AIDS Rev"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1086\/644505","article-title":"Transmission of drug-resistant HIV-1 is stabilizing in Europe","volume":"200","author":"J Vercauteren","year":"2009","journal-title":"J Infect Dis"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cid\/civ963","article-title":"Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe","volume":"62","author":"LM Hofstra","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/1471-2334-14-407","article-title":"Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe","volume":"14","author":"D Frentz","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref71","first-page":"187","article-title":"Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: Perspectives for resource-limited countries","volume":"16","author":"R Samuel","year":"2014","journal-title":"AIDS Rev"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/infdis\/jit310","article-title":"Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection","volume":"208","author":"KJ Metzner","year":"2013","journal-title":"J Infect Dis"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/QAD.0b013e328326ca77","article-title":"Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996\u20132006 in France","volume":"23","author":"ML Chaix","year":"2009","journal-title":"AIDS"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"e1001810","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: An individual-patient- and sequence-level meta-analysis","volume":"12","author":"SY Rhee","year":"2015","journal-title":"PLoS Med"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"e90710","DOI":"10.1371\/journal.pone.0090710","article-title":"Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations","volume":"9","author":"S Monge","year":"2014","journal-title":"PLoS One"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/jac\/dkv202","article-title":"Primary resistance to integrase strand-transfer inhibitors in Europe","volume":"70","author":"M Casadella","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0166902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T02:24:36Z","timestamp":1658024676000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0166902"}},"subtitle":[],"editor":[{"given":"Dimitrios","family":"Paraskevis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,13]]},"references-count":76,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0166902","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,13]]}}}